Bile acid sequestrant acid reabsorption will decrease cholesterol levels, in particular, low-density lipoprotein (commonly known as "bad cholesterol") in blood. Consequently, these drugs have been used for the treatment of hypercholesterolemia and dyslipidemia. Use of these agents as hypolipidemic agents has decreased markedly since the introduction of the statins, which are more efficacious than bile acid sequestrants at lowering LDL. They are occasionally used as an adjunct to the statins as an alternative to the fibrates (another major group of cholesterol-lowering drugs), which are thought to increase the risk of rhabdomyolysis when used with statins. The bile-acid-binding resins can raise triglycerides modestly (about
We Are Drugs to finish them after the band finished touring to support "Dopamine"—he would want to release. Several months later, Jenkins began discussing plans for a new EP release in mid-2016. Contrary to the band's previous few albums—"Out of the Vein" (2003), "Ursa Major" (2009), and "Dopamine" (2015), which were recorded over the course of four to six years—the band was limited to only one week in a studio in Texas in early 2016 to record "We Are Drugs". Jenkins stated that the success of "Dopamine" finally allowed him to stop obsessing over perfecting lyrics, something he had done in the past.